171 related articles for article (PubMed ID: 29471338)
1. Transitioning from river blindness control to elimination: steps toward stopping treatment.
Cantey PT; Roy SL; Boakye D; Mwingira U; Ottesen EA; Hopkins AD; Sodahlon YK
Int Health; 2018 Mar; 10(suppl_1):i7-i13. PubMed ID: 29471338
[TBL] [Abstract][Full Text] [Related]
2. From river blindness to river epilepsy: Implications for onchocerciasis elimination programmes.
Colebunders R; Siewe Fodjo JN; Hopkins A; Hotterbeekx A; Lakwo TL; Kalinga A; Logora MY; Basáñez MG
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007407. PubMed ID: 31318857
[No Abstract] [Full Text] [Related]
3. The role of national committees in eliminating onchocerciasis.
Griswold E; Unnasch T; Eberhard M; Nwoke BEB; Morales Z; Muheki Tukahebwa E; Kebede B; Anagbogu I; Katabarwa M; Habomugisha P; Tadesse Z; Miri ES; Evans D; Cohn D; Elhassan E; Richards F
Int Health; 2018 Mar; 10(suppl_1):i60-i70. PubMed ID: 29471337
[TBL] [Abstract][Full Text] [Related]
4. Elimination of onchocerciasis in Africa by 2025: the need for a broad perspective.
Cupp E; Sauerbrey M; Cama V; Eberhard M; Lammie PJ; Unnasch TR
Infect Dis Poverty; 2019 Jul; 8(1):50. PubMed ID: 31303176
[TBL] [Abstract][Full Text] [Related]
5. From river blindness control to elimination: bridge over troubled water.
Colebunders R; Basáñez MG; Siling K; Post RJ; Rotsaert A; Mmbando B; Suykerbuyk P; Hopkins A
Infect Dis Poverty; 2018 Mar; 7(1):21. PubMed ID: 29587844
[TBL] [Abstract][Full Text] [Related]
6. Reaching the last mile: main challenges relating to and recommendations to accelerate onchocerciasis elimination in Africa.
Gebrezgabiher G; Mekonnen Z; Yewhalaw D; Hailu A
Infect Dis Poverty; 2019 Jul; 8(1):60. PubMed ID: 31269966
[TBL] [Abstract][Full Text] [Related]
7. The positive influence the Onchocerciasis Elimination Program for the Americas has had on Africa programs.
Richards FO; Nwoke BEB; Zarroug I; Tukahebwa E; Negussu N; Higazi TB; Oguttu D; Tadesse Z; Miri E; Aziz N; Habomugisha P; Katabarwa M
Infect Dis Poverty; 2019 Jul; 8(1):52. PubMed ID: 31303175
[TBL] [Abstract][Full Text] [Related]
8. Cross-border issues: an important component of onchocerciasis elimination programmes.
Bush S; Sodahlon Y; Downs P; Mackenzie CD
Int Health; 2018 Mar; 10(suppl_1):i54-i59. PubMed ID: 29471344
[TBL] [Abstract][Full Text] [Related]
9. Elimination of onchocerciasis from Colombia: first proof of concept of river blindness elimination in the world.
Nicholls RS; Duque S; Olaya LA; López MC; Sánchez SB; Morales AL; Palma GI
Parasit Vectors; 2018 Apr; 11(1):237. PubMed ID: 29642939
[TBL] [Abstract][Full Text] [Related]
10. River Blindness: Mathematical Models for Control and Elimination.
Basáñez MG; Walker M; Turner HC; Coffeng LE; de Vlas SJ; Stolk WA
Adv Parasitol; 2016; 94():247-341. PubMed ID: 27756456
[TBL] [Abstract][Full Text] [Related]
11. "Cross-border collaboration in onchocerciasis elimination in Uganda: progress, challenges and opportunities from 2008 to 2013".
Lakwo T; Ukety T; Bakajika D; Tukahebwa E; Awaca P; Amazigo U
Global Health; 2018 Feb; 14(1):16. PubMed ID: 29409509
[TBL] [Abstract][Full Text] [Related]
12. For as Long as Necessary: Examining 30 years of MSD's Focus on Achieving Elimination of Onchocerciasis and Lymphatic Filariasis.
Gustavsen KM; Colatrella BD; McCoy T
Int Health; 2018 Mar; 10(suppl_1):i3-i6. PubMed ID: 29186497
[TBL] [Abstract][Full Text] [Related]
13. Onchocerciasis (river blindness) - more than a century of research and control.
Brattig NW; Cheke RA; Garms R
Acta Trop; 2021 Jun; 218():105677. PubMed ID: 32857984
[TBL] [Abstract][Full Text] [Related]
14. Control, elimination, and eradication of river blindness: scenarios, timelines, and ivermectin treatment needs in Africa.
Kim YE; Remme JH; Steinmann P; Stolk WA; Roungou JB; Tediosi F
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003664. PubMed ID: 25860569
[TBL] [Abstract][Full Text] [Related]
15. Eliminating onchocerciasis within the Meme River Basin of Cameroon: A social-ecological approach to understanding everyday realities and health systems.
Nji TM; Piotrowski H; Dum-Buo N; Fung EG; Dean L; Theobald S; Thomson R; Wanji S; Ozano K
PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009433. PubMed ID: 34077416
[TBL] [Abstract][Full Text] [Related]
16. Elimination of onchocerciasis in Africa by 2025: an ambitious target requires ambitious interventions.
Colebunders R; Stolk WA; Siewe Fodjo JN; Mackenzie CD; Hopkins A
Infect Dis Poverty; 2019 Oct; 8(1):83. PubMed ID: 31578157
[TBL] [Abstract][Full Text] [Related]
17. Progress towards eliminating onchocerciasis in the WHO Region of the Americas: verification of elimination of transmission in Guatemala.
Wkly Epidemiol Rec; 2016 Oct; 91(43):501-5. PubMed ID: 27801556
[No Abstract] [Full Text] [Related]
18. The Onchocerciasis Elimination Program for the Americas: a history of partnership.
Blanks J; Richards F; Beltrán F; Collins R; Alvarez E; Zea Flores G; Bauler B; Cedillos R; Heisler M; Brandling-Bennett D; Baldwin W; Bayona M; Klein R; Jacox M
Rev Panam Salud Publica; 1998 Jun; 3(6):367-74. PubMed ID: 9734217
[TBL] [Abstract][Full Text] [Related]
19. Onchocerciasis: shifting the target from control to elimination requires a new first-step-elimination mapping.
Rebollo MP; Zoure H; Ogoussan K; Sodahlon Y; Ottesen EA; Cantey PT
Int Health; 2018 Mar; 10(suppl_1):i14-i19. PubMed ID: 29471341
[TBL] [Abstract][Full Text] [Related]
20. Onchocerciasis in Yemen: moving forward towards an elimination program.
Al-Kubati AS; Mackenzie CD; Boakye D; Al-Qubati Y; Al-Samie AR; Awad IE; Thylefors B; Hopkins A
Int Health; 2018 Mar; 10(suppl_1):i89-i96. PubMed ID: 29471343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
